AbbVie is a global, research-based biopharmaceutical company formed in 2013 following separation from Abbott Laboratories. The company’s mission is to use its expertise, dedicated people and unique approach to innovation to develop and market advanced therapies that address some of the world’s most complex and serious diseases. Together with its wholly-owned subsidiary, Pharmacyclics, AbbVie employs more than 28,000 people worldwide and markets medicines in more than 170 countries. For further information on the company and its people, portfolio and commitments, please visit www.abbvie.ca. Follow @abbviecanada on Twitter or view careers on our Facebook or LinkedIn page.
À propos d’AbbVie
AbbVie est une société d’envergure mondiale centrée sur la recherche biopharmaceutique créée en 2013 à la suite de la scission des Laboratoires Abbott. La société a pour mission de mettre à profit son expertise, son personnel dévoué et son approche unique de l’innovation au développement et à la commercialisation de traitements évolués qui répondent à certaines des maladies les plus complexes et les plus graves au monde. AbbVie, y compris sa filiale à part entière, Pharmacyclics, emploie plus de 28 000 personnes et commercialise ses produits dans plus de 170 pays. Pour obtenir de plus amples renseignements sur la société, son effectif, sa gamme de produits et ses engagements, visitez le www.abbvie.ca. Suivez la société sur Twitter @abbviecanada ou consultez ses offres d’emploi sur Facebook ou LinkedIn.
At Alberta Health Services (AHS) within CancerControl Alberta (CCA), there are two main Clinical Trials Units (CTUs): the Cross Cancer Institute (CCI) and the Tom Baker Cancer Centre (TBCC). The CTUs provide trained staff and supportive services to Principal Investigators (PIs) or researchers who are conducting oncology clinical trials. The CTUs work in collaboration with Alberta Cancer Clinical Trials (ACCT) – Business Development Unit (BDU) which provides a provincial hub for communications, collaboration and coordination. This entire entity within CCA comprising of the CTUs and the BDU is collectively referred to as “Alberta Cancer Clinical Trials” or “ACCT”.
Alberta Health Services (AHS) is Canada’s first and largest province-wide, fully-integrated health system, responsible for delivering health services to the over four million people living in Alberta, as well as to some residents of Saskatchewan, B.C. and the Northwest Territories. AHS programs and services are offered at over 650 facilities throughout the province, including hospitals, clinics, continuing care facilities, cancer centres, mental health facilities and community health sites. The province also has an extensive network of community-based services designed to assist Albertans maintain and/or improve health status.
As Alberta’s largest provider of care, AHS partners with Alberta’s universities, funders and others to enable frontline teams to test ideas and adopt them. By integrating research and innovation into the delivery of care, AHS can nurture health research breakthroughs, innovations and new knowledge to the point where they generate tangible, real world clinical value.
Alberta Innovates is building on Alberta’s strengths in health, environment, energy, food, fibre and emerging technologies and is partnering with organizations to improve health and clinical research across the province. Managed by Alberta Innovates, the Alberta Clinical Research Consortium (ACRC) initiative aims to build capacity, increase efficiency and streamline the set-up and conduct of clinical health research in Alberta.